Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

Laura Mannonen; Hannimari Kallio-Kokko; Raisa Loginov; Anu Jääskeläinen; Pia Jokela; Jenni Antikainen; Paula Väre; Eliisa Kekäläinen; Satu Kurkela; Hanna Jarva; Maija Lappalainen

doi:10.1016/j.jmoldx.2021.01.005

Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

Laura Mannonen, Hannimari Kallio-Kokko, Raisa Loginov, Anu Jääskeläinen, Pia Jokela, Jenni Antikainen, Paula Väre, Eliisa Kekäläinen, Satu Kurkela, Hanna Jarva, Maija Lappalainen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Journal of Molecular Diagnostics
Volume	23
Issue number	4
Pages (from-to)	407-416
Number of pages	10
ISSN	1525-1578
DOIs	https://doi.org/10.1016/j.jmoldx.2021.01.005
Publication status	Published - Apr 2021
MoE publication type	A1 Journal article-refereed

Fields of Science

3111 Biomedicine

Access to Document

10.1016/j.jmoldx.2021.01.005

PIIS1525157821000076Final published version, 433 KBLicence: CC BY-NC-ND
Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNAProof, 377 KBLicence: CC BY-NC-ND

Cite this

Mannonen, L., Kallio-Kokko, H., Loginov, R., Jääskeläinen, A., Jokela, P., Antikainen, J., Väre, P., Kekäläinen, E., Kurkela, S., Jarva, H., & Lappalainen, M. (2021). Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA. Journal of Molecular Diagnostics, 23(4), 407-416. https://doi.org/10.1016/j.jmoldx.2021.01.005

@article{dd5253bd8f684203aa8c2c774a37b5f8,

title = "Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA",

keywords = "3111 Biomedicine",

author = "Laura Mannonen and Hannimari Kallio-Kokko and Raisa Loginov and Anu J{\"a}{\"a}skel{\"a}inen and Pia Jokela and Jenni Antikainen and Paula V{\"a}re and Eliisa Kek{\"a}l{\"a}inen and Satu Kurkela and Hanna Jarva and Maija Lappalainen",

year = "2021",

month = apr,

doi = "10.1016/j.jmoldx.2021.01.005",

language = "English",

volume = "23",

pages = "407--416",

journal = "Journal of Molecular Diagnostics",

issn = "1525-1578",

publisher = "Elsevier B.V.",

number = "4",

}

Mannonen, L , Kallio-Kokko, H , Loginov, R , Jääskeläinen, A , Jokela, P , Antikainen, J, Väre, P, Kekäläinen, E , Kurkela, S , Jarva, H & Lappalainen, M 2021, 'Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA', Journal of Molecular Diagnostics, vol. 23, no. 4, pp. 407-416. https://doi.org/10.1016/j.jmoldx.2021.01.005

Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA. / Mannonen, Laura ; Kallio-Kokko, Hannimari ; Loginov, Raisa et al.
In: Journal of Molecular Diagnostics, Vol. 23, No. 4, 04.2021, p. 407-416.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

AU - Mannonen, Laura

AU - Kallio-Kokko, Hannimari

AU - Loginov, Raisa

AU - Jääskeläinen, Anu

AU - Jokela, Pia

AU - Antikainen, Jenni

AU - Väre, Paula

AU - Kekäläinen, Eliisa

AU - Kurkela, Satu

AU - Jarva, Hanna

AU - Lappalainen, Maija

PY - 2021/4

Y1 - 2021/4

KW - 3111 Biomedicine

U2 - 10.1016/j.jmoldx.2021.01.005

DO - 10.1016/j.jmoldx.2021.01.005

M3 - Article

SN - 1525-1578

VL - 23

SP - 407

EP - 416

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

IS - 4

ER -